Диссертация (1140952), страница 19
Текст из файла (страница 19)
Т. 93. № 7. — C. 3115-20.URL: http://ghr.nlm.nih.gov/gene/SERPINE1 от 15.12.15.Smith N.L., Chen M.H., Dehghan A., Strachan D.P., Basu S., Soranzo N., Hayward C.,Rudan I., Sabater-Lleal M., Bis J.C., de Maat M.P., Rumley A., Kong X., Yang Q.,Williams F.M., Vitart V., Campbell H., Malarstig A., Wiggins K.L., Van Duijn C.M.,McArdle W.L., Pankow J.S., Johnson A.D., Silveira A., McKnight B., Uitterlinden A.G.,Wellcome Trust Case Control C., Aleksic N., Meigs J.B., Peters A., Koenig W.,Cushman M., Kathiresan S., Rotter J.I., Bovill E.G., Hofman A., Boerwinkle E., ToflerG.H., Peden J.F., Psaty B.M., Leebeek F., Folsom A.R., Larson M.G., Spector T.D.,Wright A.F., Wilson J.F., Hamsten A., Lumley T., Witteman J.C., Tang W., O'DonnellC.J.
Novel associations of multiple genetic loci with plasma levels of factor VII, factorVIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Researchin Genome Epidemiology) Consortium // Circulation. 2010. Т. 121. № 12. — C. 138292.Volonghi I., Pezzini A., Del Zotto E., Giossi A., Costa P., Ferrari D., Padovani A. Role ofCOL4A1 in basement-membrane integrity and cerebral small-vessel disease. TheCOL4A1 stroke syndrome // Curr Med Chem.
2010. Т. 17. № 13. — C. 1317-24.125139.140.141.142.143.144.145.146.147.148.Girolami A., Ruzzon E., Tezza F., Scandellari R., Scapin M., Scarparo P. Congenital FXdeficiency combined with other clotting defects or with other abnormalities: a criticalevaluation of the literature // Haemophilia. 2008. Т. 14.
№ 2. — C. 323-8.Tsai C.H., Lee S.S., Chang Y.C. Hypoxic regulation of plasminogen activator inhibitor-1expression in human buccal mucosa fibroblasts stimulated with arecoline // J Oral PatholMed. 2014.Russell J.A. Management of sepsis // N Engl J Med. 2006. Т. 355. № 16. — C. 1699-713.Hoirisch-Clapauch S., Nardi A.E. A role for tissue plasminogen activator in thromboticthrombocytopenic purpura // Med Hypotheses.
2014. Т. 83. № 6. — C. 747-750.Liu L., Ling J., Ma Z., Yuan Q., Pan J., Yang H. Changes in von Willebrand factor andADAMTS-13 in patients following arthroplasty // Mol Med Rep. 2014.Mannucci P.M., Vanoli M., Forza I., Canciani M.T., Scorza R. Von Willebrand factorcleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases(systemic lupus erythematosus and systemic sclerosis) // Haematologica. 2003. Т.
88. №8. — C. 914-8.McClelland R., Wilson D., Leake R., Finlay P., Nicholson R. A multicentre study into thereliability of steroid receptor immunocytochemical assay quantification. British QualityControl Group. // Eur J Cancer. 1991. Т. 27 (6). — C. 711-715.Дюжева Е.В., Калинина Е.А., Кузьмичев Л.Н., Коган Е.А.
Иммуногистохимическоеисследование эндометрия в рамках ВРТ // Вестник РУДН серия МедицинаАкушерство и Гинекология. 2009. № 6. — C. 98-104.Yalcintepe S., Ozdemir O., Hacivelioglu S.O., Akurut C., Koc E., Uludag A., Cosar E.,Silan F. Multiple Inherited Thrombophilic Gene Polymorphisms in SpontaneousAbortions in Turkish Population // Int J Mol Cell Med. 2015.
Т. 4. № 2. — C. 120-7.Diao H., Aplin J.D., Xiao S., Chun J., Li Z., Chen S., Ye X. Altered spatiotemporalexpression of collagen types I, III, IV, and VI in Lpar3-deficient peri-implantation mouseuterus // Biol Reprod. 2011. Т. 84. № 2. — C. 255-65.126.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
